Drug Type Small molecule drug |
Synonyms OSU-DY7 |
Target |
Action- |
Mechanism p38 MAPK stimulants(P38丝裂原活化蛋白激酶刺激剂) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H27NO2 |
InChIKeyBQIVLCKDQGCRBM-OAHLLOKOSA-N |
CAS Registry1358779-41-5 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Burkitt Lymphoma | Preclinical | Taiwan Province | 01 Jun 2011 | |
| Chronic Lymphocytic Leukemia | Preclinical | Taiwan Province | 01 Jun 2011 |





